上臂深静脉血栓的最佳管理:静脉胸廓出口综合征是否被低估?
本文综述上臂深静脉血栓(UEDVT)的管理。指出用力血栓形成应归为继发性,静脉胸廓出口综合征常被漏诊;对疑似该综合征者应更积极溶栓,以避免长期症状。
要点
- 用力血栓形成应归为继发性UEDVT,而非特发性。
- 静脉胸廓出口综合征常被漏诊,需提高警惕。
- 对疑似该综合征者,积极溶栓可降低长期症状率。
核心结论
- 对疑似静脉胸廓出口综合征的UEDVT患者,应更积极采用溶栓治疗。
- 正确治疗用力血栓形成可将长期症状率从50%降至接近0%。
研究设计与样本
- 综合文献综述,检索Medline和Google Scholar,并手动审查初始报告中的相关引文,涵盖外科和内科期刊。
主要发现
- UEDVT约占所有DVT病例的10%。
- 导管和起搏器相关血栓形成是继发性UEDVT最常见原因,但常无症状。
- 用力血栓形成被提议归为继发性UEDVT,将「原发性」限于真正特发性者。
- 对真性原发性或无机械性原因的继发性UEDVT,抗凝仍是首选治疗,通常3个月或所需导管留置期间。
- 许多用力血栓形成病例可能因过于狭窄地遵循该方案而被漏诊。
关键数值与推荐
- 抗凝通常持续3个月或所需导管留置期间。
- 长期症状率可从50%降至接近0%。
临床怎么用
- 对任何合理怀疑静脉胸廓出口综合征的患者,应更积极进行溶栓治疗。
- 不应将用力血栓形成简单归为原发性UEDVT并按常规抗凝处理。
局限性
- 本文为文献综述,未报告原始研究的具体样本量、置信区间或P值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Upper extremity deep vein thrombosis (UEDVT) accounts for ~10% of all cases of DVT. In the most widely referenced general review of DVT, the American Academy of Chest Physicians essentially recommended that UEDVT be treated identically to that of lower extremity DVT, with anticoagulation the default therapy. However, the medical literature has not differentiated well between DVT in the arm vs DVT in the leg and has not emphasized the effects of the costoclavicular junction and the lack of the effect of gravity to the point at which UEDVT due to extrinsic bony compression at the costoclavicular junction is classified as "primary." METHODS: We performed a comprehensive literature review, beginning with both Medline and Google Scholar searches, in addition to collected references. Next, we manually reviewed the relevant citations within the initial reports studied. Both surgical and medical journals were explored. RESULTS: It has been proposed that "effort thrombosis" should be classified as a secondary cause of UEDVT, limiting the definition of "primary" to that which is truly idiopathic. Other causes of secondary UEDVT include catheter- and pacemaker-related thrombosis (the most common cause but often asymptomatic), thrombosis related to malignancy and hypercoagulable conditions, and the rare case of thrombosis due to compression of the vein by a focal malignancy or other space-occupying lesion. In true primary UEDVT and those secondary cases in which no mechanical cause is present or can be corrected, anticoagulation remains the treatment of choice, usually for 3 months or the duration of a needed catheter. However, evidence has suggested that many cases of effort thrombosis are likely missed by a too-narrow adherence to this protocol. CONCLUSIONS: Because proper treatment of effort thrombosis would decrease the long-term symptomatic status rate from 50% to almost 0% and because these are healthy patients with a long lifespan, we believe that a more aggressive attitude toward thrombolysis should be followed for any patient with a reasonable degree of suspicion for venous thoracic outlet syndrome.
引用
- Illig KA, Gober L. Optimal management of upper extremity deep vein thrombosis: Is venous thoracic outlet syndrome underrecognized? J Vasc Surg Venous Lymphat Disord. 2021. PMID: 34352421. doi:10.1016/j.jvsv.2021.07.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。